Knights of Columbus Asset Advisors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-36,962	Closed	-$745K	–	336
2021 Q3	$745K	Buy	36,962 +50	+0.1%	+$1.38K	0.07%	234
2021 Q2	$1.38M	Sell	36,912 -20,584	-36%	-$631K	0.13%	221
2021 Q1	$1.47M	Buy	57,496 +8,125	+16%	+$208K	0.14%	222
2020 Q4	$1.09M	Buy	49,371 +17	+0%	+$374	0.12%	247
2020 Q3	$888K	Sell	49,354 -7,324	-13%	-$152K	0.11%	241
2020 Q2	$1.44M	Buy	+56,678	New	+$1.22M	0.18%	180

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Knights of Columbus Asset Advisors's DRNA Position: Q4 2021 in Review

Knights of Columbus Asset Advisors sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 36,962 shares — an estimated $745K sold.

Knights of Columbus Asset Advisors first reported a position in DRNA in Q2 2020 and held it in 6 quarters. The position peaked at $1.47M in Q1 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Knights of Columbus Asset Advisors reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Knights of Columbus Asset Advisors sold 36,962 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $745K.
Knights of Columbus Asset Advisors first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2020 and held it in 6 quarters.
Knights of Columbus Asset Advisors's Dicerna Pharmaceuticals, Inc. position peaked at $1.47M in Q1 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Knights of Columbus Asset Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.